Home
Live Updates
Dr Kirkwood on the Evolving Treatment of Resected Melanoma : comparemela.com
Dr Kirkwood on the Evolving Treatment of Resected Melanoma
John M. Kirkwood, MD, discusses the significance of the FDA approval of adjuvant nivolumab for patients with resected stage IIB or IIC melanoma.
Related Keywords
Johnm Kirkwood ,
,
University Of Pittsburgh ,
Division Of Hematology Oncology ,
Oncologic Drug Advisory Committee ,
Service Professor Of Medicine ,
Skin Cancer Program ,
Distinguished Service Professor ,
Thomas Usher Professor ,
Translational Science ,
Drug Advisory Committee ,
D ,
Fda Approval Of Adjuvant Nivolumab ,
Patients With Resected Stage Iib Or Iic Melanoma ,
comparemela.com © 2020. All Rights Reserved.